Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$13.67 - $17.77 $183,178 - $238,118
-13,400 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$10.89 - $21.47 $145,926 - $287,698
13,400 New
13,400 $197,000
Q4 2018

Feb 12, 2019

SELL
$22.03 - $32.01 $335,803 - $487,928
-15,243 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$30.0 - $40.85 $457,290 - $622,676
15,243 New
15,243 $482,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $127M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.